计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| B651791-5mg |
5mg |
期货 ![]() |
| |
| B651791-10mg |
10mg |
期货 ![]() |
| |
| B651791-25mg |
25mg |
期货 ![]() |
| |
| B651791-50mg |
50mg |
期货 ![]() |
| |
| B651791-100mg |
100mg |
期货 ![]() |
|
| 规格或纯度 | ≥99% |
|---|---|
| 英文名称 | BI 689648 |
| 生化机理 | BI 689648 是一种新型、高选择性醛固酮合成酶抑制剂,可抑制 CYP11B1 和 CYP11B2,IC 50 s 分别为 310 和 2.1 nM。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 产品介绍 |
BI 689648 is a novel, highly selective aldosterone synthase inhibitor which can inhibit CYP11B1 and CYP11B2 with IC 50 s of 310 and 2.1 nM, respectively. In Vitro Compare with the FADs and LCI699, BI 689648 is highly selective in vitro , providing an IC 50 for CYP11B2 of 2.1 nM and a selectivity factor of 149 over CYP11B1. FAD286, by comparison, shows a similar IC 50 for CYP11B2 (2.5 nM); however, its greater potency against CYP11B1 (94 nM) results in a comparatively modest selectivity factor of 38, approximately 4-fold less than BI 689648. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo After oral administration in cyno monkeys, BI 689648 (5 mg/kg) exhibits a peak plasma concentration of ~500 nM. For BI 689648 (aldosterone EC 50 =2 nM), appreciable changes in 11-DOC are only noted at plasma concentrations >2000 nM or >1000-fold its aldosterone EC 50 while FAD286 shows a window of ~100-fold. BI 689648 exhibits minimal impact on 11-DC and only at very high plasma concentrations (~10 μM) . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:IC50: 310 nM (CYP11B1), 2.1 nM (CYP11B2) |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 6-[5-(methoxymethyl)pyridin-3-yl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide |
| INCHI | 1S/C16H18N4O2/c1-22-10-11-5-13(8-18-7-11)14-6-12-3-2-4-20(16(17)21)15(12)19-9-14/h5-9H,2-4,10H2,1H3,(H2,17,21) |
| InChi Key | DJFDCVNQDFICKV-UHFFFAOYSA-N |
| Smiles | COCC1=CC(=CN=C1)C2=CC3=C(N=C2)N(CCC3)C(=O)N |
| Isomeric SMILES | COCC1=CC(=CN=C1)C2=CC3=C(N=C2)N(CCC3)C(=O)N |
| PubChem CID | 86305663 |
| MeSH Entry Terms | 6-(5-methoxymethylpyridin-3-yl)-3,4-dihydro-2H-(1,8)naphthyridine-1-carboxylic acid amide;BI 689648 |
| 分子量 | 298.34 |
| 溶解性 | DMSO : 30 mg/mL (100.56 mM; Need ultrasonic and warming) |
|---|---|
| 分子量 | 298.340 g/mol |
| XLogP3 | 0.600 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 298.143 Da |
| 单同位素质量Monoisotopic Mass | 298.143 Da |
| 拓扑极表面积Topological Polar Surface Area | 81.300 Ų |
| 重原子数Heavy Atom Count | 22 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 392.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |